Patents by Inventor Satinder Mohan Jain

Satinder Mohan Jain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs
    Publication number: 20080138452
    Abstract: The present invention relates to a composition useful for hepatocurative effect against CYP 450 bio-activation hepatotoxicity induced by drugs, said composition comprising an extract from Emblica officinalis and optionally pharmaceutically acceptable additives and method of treating drug induced hepatotoxicity
    Type: Application
    Filed: December 21, 2007
    Publication date: June 12, 2008
    Inventors: Rakesh Kamal Johri, Sheikh Tasaduq Abdullah, Kuldeep Singh, Devinder Kumar Gupta, Bal Krishan Kapahi, Dilip Manikrao Mondhe, Satinder Mohan Jain, Om Parkash Suri, Kasturi Lal Bedi, Ghulam Nabi Qazi
  • Hepatocurative effect of against CYP 450 bio-activation hepatotoxicity of drugs
    Patent number: 7001619
    Abstract: The present invention relates to a composition useful for hepatocurative effect against CYP 450 bio-activation hepatotoxicity induced by drugs, said composition comprising an extract from Emblica officinalis and optionally pharmaceutically acceptable additives and method of treating drug induced hepatotoxicity.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: February 21, 2006
    Assignee: Council of Scientific and Industrial Research
    Inventors: Rakesh Kamal Johri, Sheikh Tasaduq Abdullah, Kuldeep Singh, Devinder Kumar Gupta, Bal Krishan Kapahi, Dilip Manikrao Mondhe, Satinder Mohan Jain, Om Parkash Suri, Kasturi Lal Bedi, Ghulam Nabi Qazi
  • Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs
    Publication number: 20030185922
    Abstract: The present invention relates to a composition useful for hepatocurative effect against CYP 450 bio-activation hepatotoxicity induced by drugs, said composition comprising an extract from Emblica officinalis and optionally pharmaceutically acceptable additives and method of treating drug induced hepatotoxicity
    Type: Application
    Filed: March 27, 2002
    Publication date: October 2, 2003
    Inventors: Rakesh Kamal Johri, Sheikh Tasaduq Abdullah, Kuldeep Singh, Devinder Kumar Gupta, Bal Krishan Kapahi, Dilip Manikrao Mondhe, Satinder Mohan Jain, Om Parkash Suri, Kasturi Lal Bedi, Ghulam Nabi Qazi